NEULANDLABNSENeuland Laboratories Limited· PharmaceuticalsLowNeutral
Announced Thu, 19 Jun · 18:04 IST

Neuland Laboratories Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Neuland Laboratories has informed the stock exchanges that its management will participate in a group analyst and investor meeting on June 25, 2025. The meeting is a non-deal roadshow (NDR) organized by B&K Securities, to be held in Hyderabad. A non-deal roadshow is a routine investor engagement where the company presents to investors without raising fresh capital. The company has noted that the schedule and participant list are subject to change. The intimation has been filed under SEBI's Regulation 30 of the Listing Obligations and Disclosure Requirements Regulations, 2015.

Likely market impact

This is a routine disclosure about investor engagement and does not involve any new business development, financial results, or capital action. It is unlikely to have a direct material impact on the stock price, though it provides the company's management an opportunity to share its business outlook with institutional investors.